Nutex Health Debt to Equity Ratio 2016-2026 | NUTX
Current and historical debt to equity ratio values for Nutex Health (NUTX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Nutex Health debt/equity for the three months ending June 30, 2026 was 0.59.
| Nutex Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-06-30 | $0.46B | $0.51B | 0.90 |
| 2026-03-31 | $0.52B | $0.44B | 1.17 |
| 2025-12-31 | $0.50B | $0.42B | 1.17 |
| 2025-09-30 | $0.53B | $0.44B | 1.20 |
| 2025-06-30 | $0.50B | $0.34B | 1.50 |
| 2025-03-31 | $0.51B | $0.26B | 1.99 |
| 2024-12-31 | $0.47B | $0.19B | 2.48 |
| 2024-09-30 | $0.36B | $0.08B | 4.50 |
| 2024-06-30 | $0.34B | $0.08B | 4.15 |
| 2024-03-31 | $0.32B | $0.08B | 4.05 |
| 2023-12-31 | $0.32B | $0.08B | 4.03 |
| 2023-09-30 | $0.38B | $0.11B | 3.57 |
| 2023-06-30 | $0.33B | $0.11B | 3.03 |
| 2023-03-31 | $0.32B | $0.11B | 2.93 |
| 2022-12-31 | $0.31B | $0.12B | 2.59 |
| 2022-09-30 | $0.30B | $0.13B | 2.28 |
| 2022-06-30 | $0.31B | $0.57B | 0.54 |
| 2022-03-31 | $0.01B | $0.07B | 0.14 |
| 2021-12-31 | $0.20B | $0.19B | 1.06 |
| 2021-09-30 | $0.01B | $0.07B | 0.13 |
| 2021-06-30 | $0.01B | $0.07B | 0.15 |
| 2021-03-31 | $0.05B | $0.07B | 0.75 |
| 2020-12-31 | $0.00B | $0.00B | -1.15 |
| 2020-09-30 | $0.00B | $0.01B | 0.30 |
| 2020-06-30 | $0.00B | $0.01B | 0.25 |
| 2020-03-31 | $0.00B | $0.00B | 2.56 |
| 2019-12-31 | $0.01B | $0.00B | 2.60 |
| 2019-09-30 | $0.00B | $0.00B | 2.29 |
| 2019-06-30 | $0.00B | $0.00B | 1.31 |
| 2019-03-31 | $0.00B | $0.00B | 1.00 |
| 2018-12-31 | $0.00B | $0.00B | -1.30 |
| 2018-09-30 | $0.00B | $0.00B | 0.78 |
| 2018-06-30 | $0.00B | $0.00B | 0.60 |
| 2018-03-31 | $0.00B | $0.00B | 0.50 |
| 2017-12-31 | $0.00B | $0.00B | 0.41 |
| 2017-09-30 | $0.00B | $0.01B | 0.13 |
| 2017-06-30 | $0.00B | $0.01B | 0.10 |
| 2017-03-31 | $0.00B | $0.00B | 0.00 |
| 2016-12-31 | $0.01B | $-0.01B | -1.09 |
| 2016-09-30 | $0.00B | $0.00B | 0.00 |
| 2016-06-30 | $0.00B | $0.00B | 0.00 |
| 2016-03-31 | $0.00B | 0.00 | |
| 2015-12-31 | $0.00B | 0.00 | |
| 2015-09-30 | $0.00B | 0.00 | |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.430B | $0.875B |
| Nutex Health Inc. is a physician-led, technology-enabled healthcare services company. The Company's operating divisions include Hospital division and Population Health Management division. Hospital division implements and operates different health care models, including micro hospitals, specialty hospitals and hospital outpatient departments. Population Health Management division owns and operates provider networks such as Independent Physician Associations. Nutex Health Inc., formerly known as Clinigence Holdings Inc., is based in HOUSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.899B | 26.08 |
| CVS Health (CVS) | United States | $113.624B | 11.33 |
| HCA Healthcare (HCA) | United States | $92.600B | 14.40 |
| Elevance Health (ELV) | United States | $89.122B | 13.98 |
| Cencora (COR) | United States | $58.924B | 18.00 |
| Natera (NTRA) | United States | $53.245B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.010B | 18.34 |
| Viatris (VTRS) | United States | $19.469B | 6.73 |
| Medpace Holdings (MEDP) | United States | $17.091B | 35.89 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.888B | 0.00 |
| DiDi Global (DIDIY) | China | $16.776B | 184.00 |
| Revvity (RVTY) | United States | $16.007B | 26.81 |
| Solventum (SOLV) | United States | $15.123B | 12.51 |
| Charles River Laboratories (CRL) | United States | $13.274B | 28.09 |
| ICON (ICLR) | Ireland | $12.565B | 17.08 |
| BrightSpring Health Services (BTSG) | United States | $11.235B | 38.63 |
| Avantor (AVTR) | United States | $10.497B | 18.93 |
| BioMerieux (BMXMF) | France | $9.856B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.472B | 83.28 |
| HealthEquity (HQY) | United States | $7.870B | 25.64 |
| Sonic Healthcare (SKHHY) | Australia | $6.732B | 0.00 |
| PACS (PACS) | United States | $6.666B | 22.40 |
| GETINGE (GNGBY) | Sweden | $6.516B | 18.40 |
| CochLear (CHEOY) | Australia | $6.200B | 0.00 |
| MiniMed (MMED) | United States | $6.131B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.021B | 22.77 |
| Sotera Health (SHC) | United States | $5.345B | 22.03 |
| Concentras Parent (CON) | United States | $4.523B | 22.31 |
| Organon (OGN) | United States | $3.593B | 4.56 |
| GeneDx Holdings (WGS) | United States | $3.015B | 280.83 |
| CareDx (CDNA) | United States | $2.785B | 316.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.107B | 12.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.103B | 0.00 |
| Progyny (PGNY) | United States | $2.082B | 29.49 |
| Establishment Labs Holdings (ESTA) | United States | $2.065B | 0.00 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $2.011B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.839B | 0.00 |
| Freenome (FRNM) | United States | $1.838B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.735B | 66.25 |
| Alignment Healthcare (ALHC) | United States | $1.732B | 43.95 |
| Agilon Health (AGL) | United States | $1.497B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Ardent Health (ARDT) | United States | $1.478B | 8.45 |
| Omada Health (OMDA) | United States | $1.251B | 255.38 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.158B | 22.53 |
| Teladoc Health (TDOC) | United States | $1.145B | 0.00 |
| CryoPort (CYRX) | United States | $0.862B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.677B | 0.00 |
| Forward Industries (FWDI) | United States | $0.569B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.489B | 10.11 |
| Strata Critical Medical (SRTA) | United States | $0.472B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.378B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.48 |
| Biodesix (BDSX) | United States | $0.308B | 0.00 |
| Embecta (EMBC) | United States | $0.300B | 2.59 |
| So-Young (SY) | China | $0.279B | 0.00 |
| LifeMD (LFMD) | United States | $0.155B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.101B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.097B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.082B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.073B | 8.67 |
| Tevogen (TVGN) | United States | $0.051B | 0.00 |
| DocGo (DCGO) | United States | $0.036B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |